Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$23.42 USD
-1.05 (-4.29%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $23.44 +0.02 (0.09%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Cash flow Statements
Fiscal Year End for Surgery Partners, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | 135.30 | 87.00 | 70.70 | 1.30 | 45.10 |
Depreciation/Amortization & Depletion | 118.10 | 114.80 | 98.80 | 94.80 | 76.50 |
Net Change from Assets/Liabilities | -63.50 | -160.70 | -181.30 | 75.90 | -68.80 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 103.90 | 117.70 | 98.90 | 74.90 | 76.70 |
Net Cash From Operating Activities | 293.80 | 158.80 | 87.10 | 246.90 | 129.50 |
Property & Equipment | -63.00 | -67.70 | -51.60 | 15.60 | -73.60 |
Acquisition/ Disposition of Subsidiaries | -80.00 | -146.40 | -285.80 | -104.60 | 3.80 |
Investments | -48.90 | -82.30 | 5.40 | 0.00 | -15.20 |
Other Investing Activities | -33.70 | -11.50 | 0.30 | 0.60 | -0.20 |
Net Cash from Investing Activities | -225.60 | -307.90 | -331.70 | -88.40 | -85.20 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.00 | 882.90 | 581.80 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | 19.50 | -655.50 | -43.80 | 213.10 | 16.10 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | -146.10 | -146.80 | -136.10 | -109.60 | -121.20 |
Other Financing Activities | -28.60 | -38.50 | -85.60 | -36.80 | -30.80 |
Net Cash from Financing Activities | -155.20 | 42.10 | 316.30 | 66.70 | -135.90 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -87.00 | -107.00 | 71.70 | 225.20 | -91.60 |
Cash at Beginning of Period | 282.90 | 389.90 | 318.20 | 93.00 | 184.60 |
Cash at End of Period | 195.90 | 282.90 | 389.90 | 318.20 | 93.00 |
Diluted Net EPS | -0.09 | -0.59 | -1.12 | -3.19 | -2.29 |
Fiscal Year End for Surgery Partners, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | 135.30 | 88.60 | 58.90 | 1.20 |
Depreciation/Amortization & Depletion | NA | 118.10 | 87.00 | 58.10 | 33.70 |
Net Change from Assets/Liabilities | NA | -63.50 | 2.20 | -19.60 | 11.40 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 103.90 | 53.40 | 29.20 | 28.20 |
Net Cash From Operating Activities | NA | 293.80 | 231.20 | 126.60 | 74.50 |
Property & Equipment | NA | -63.00 | -43.20 | -24.00 | -16.30 |
Acquisition/ Disposition of Subsidiaries | NA | -80.00 | -48.80 | -43.50 | -40.70 |
Investments | NA | -48.90 | -49.20 | -48.40 | -9.60 |
Other Investing Activities | NA | -33.70 | -26.30 | -26.00 | -4.10 |
Net Cash from Investing Activities | NA | -225.60 | -167.50 | -141.90 | -70.70 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 19.50 | 12.30 | -5.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | -146.10 | -111.00 | -76.90 | -41.90 |
Other Financing Activities | NA | -28.60 | -11.90 | -8.30 | 0.70 |
Net Cash from Financing Activities | NA | -155.20 | -110.60 | -90.20 | -41.20 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -87.00 | -46.90 | -105.50 | -37.40 |
Cash at Beginning of Period | NA | 282.90 | 282.90 | 282.90 | 282.90 |
Cash at End of Period | NA | 195.90 | 236.00 | 177.40 | 245.50 |
Diluted Net EPS | NA | 0.00 | -0.04 | 0.15 | -0.20 |